These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 35705237)

  • 1. Long-term Behavioral Changes During the COVID-19 Pandemic and Impact of Vaccination in Patients With Inflammatory Rheumatic Diseases.
    Glintborg B; Jensen DV; Terslev L; Hendricks O; Østergaard M; Rasmussen SH; Jensen MP; Adelsten T; Colic A; Danebod K; Kildemand M; Loft AG; Munk HL; Pedersen JK; Østgård RD; Sørensen CM; Krogh NS; Agerbo JN; Ziegler C; Hetland ML
    J Rheumatol; 2022 Oct; 49(10):1163-1172. PubMed ID: 35705237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-protection strategies and health behaviour in patients with inflammatory rheumatic diseases during the COVID-19 pandemic: results and predictors in more than 12 000 patients with inflammatory rheumatic diseases followed in the Danish DANBIO registry.
    Glintborg B; Jensen DV; Engel S; Terslev L; Pfeiffer Jensen M; Hendricks O; Ostergaard M; Horskjær Rasmussen S; Adelsten T; Colic A; Danebod K; Kildemand M; Loft AG; Munk HL; Pedersen JK; Østgård RD; Møller Sørensen C; Krogh NS; Agerbo J; Ziegler C; Hetland M
    RMD Open; 2021 Jan; 7(1):. PubMed ID: 33402443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD.
    Hasseli R; Mueller-Ladner U; Schmeiser T; Hoyer BF; Krause A; Lorenz HM; Regierer AC; Richter JG; Strangfeld A; Voll RE; Pfeil A; Schulze-Koops H; Specker C
    RMD Open; 2020 Sep; 6(2):. PubMed ID: 32878994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics and outcomes of SARS-CoV-2 breakthrough infections among double-vaccinated and triple-vaccinated patients with inflammatory rheumatic diseases.
    Hasseli R; Richter JG; Hoyer BF; Lorenz HM; Pfeil A; Regierer AC; Schmeiser T; Strangfeld A; Voll RE; Krause A; Reckert S; Gräßler A; Saar P; Kapelle A; Backhaus M; Blank N; Henes J; Osiek S; Knothe A; Hoese G; Brandt-Jürgens J; Maltzahn A; Specker C; Müller-Ladner U; Schulze-Koops H; ;
    RMD Open; 2023 Apr; 9(2):. PubMed ID: 37068915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perceived Risk of SARS-CoV-2 at the Start of the COVID-19 Pandemic and Subsequent Vaccination Attitudes in Patients With Rheumatic Diseases: A Longitudinal Analysis.
    Duculan R; Mancuso CA
    J Clin Rheumatol; 2022 Jun; 28(4):190-195. PubMed ID: 35067512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological response to SARS-CoV-2 vaccination in patients with inflammatory rheumatic disease treated with disease modifying anti-rheumatic drugs: A cohort study and a meta-analysis.
    Auroux M; Laurent B; Coste B; Massy E; Mercier A; Durieu I; Confavreux CB; Lega JC; Mainbourg S; Coury F
    Joint Bone Spine; 2022 Oct; 89(5):105380. PubMed ID: 35490940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cluster analysis reveals three main patterns of beliefs and intention with respect to SARS-CoV-2 vaccination in patients with autoimmune and inflammatory diseases.
    Felten R; Dubois M; Ugarte-Gil MF; Chaudier A; Kawka L; Bergier H; Costecalde C; Pijnenburg L; Fort J; Chatelus E; Sordet C; Javier RM; Gottenberg JE; Sibilia J; Fuentes-Silva YJ; Arnaud L
    Rheumatology (Oxford); 2021 Oct; 60(SI):SI68-SI76. PubMed ID: 33983432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Argentinean cohort of patients with rheumatic and immune-mediated diseases vaccinated for SARS-CoV-2: the SAR-CoVAC Registry-protocol and preliminary data.
    Isnardi CA; Schneeberger EE; Kreimer JL; Luna PC; Echeverría C; Roberts K; de la Vega MC; Virasoro BM; Landi M; Quintana R; Exeni MED; Kogan N; Petkovic I; Pereira D; De Los Ángeles Correa M; Zelaya MD; Tissera Y; Elkin MSG; Pisoni CN; Alonso C; Cogo AK; Cosatti MA; García L; Retamozo C; de Los Ángeles Severina M; Nieto RE; Rosemffet M; Mussano E; Bertoli A; Savio VG; Cosentino V; Pons-Estel GJ
    Clin Rheumatol; 2022 Oct; 41(10):3199-3209. PubMed ID: 35760939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omicron variant dominance and anti-SARS-CoV-2 vaccination are key determinants for a milder course of COVID-19 in patients with systemic autoimmune rheumatic diseases.
    Papagoras C; Zioga N; Papadopoulos V; Gerolymatou N; Kalavri E; Bounos C; Simopoulou T; Fragoulis GE; Panopoulos S; Fragiadaki K; Evangelatos G; Bournia VK; Arida A; Karamanakos A; Pappa M; Kravvariti E; Deftereou K; Kougkas N; Zampeli E; Kataxaki E; Melissaropoulos K; Barouta G; Panagiotopoulos A; Koutsianas C; Liossis SN; Georgiou P; Dimitroulas T; Tektonidou MG; Bogdanos DP; Elezoglou A; Voulgari PV; Sfikakis PP; Vassilopoulos D
    Clin Rheumatol; 2023 Dec; 42(12):3375-3385. PubMed ID: 37731083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CVAPPS: A Cross-Sectional Study of SARS-CoV-2 Vaccine Acceptance, Perceptions, and Post-Vaccination Side Effects among Rheumatic Disease Patients in Kuwait.
    Baroun F; Albasri A; Abutiban F; Alhajeri H
    Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992250
    [No Abstract]   [Full Text] [Related]  

  • 11. Exploring the attitudes, concerns, and knowledge regarding COVID-19 vaccine by the parents of children with rheumatic disease: Cross-sectional online survey.
    Akgün Ö; Kayaalp GK; Demirkan FG; Çakmak F; Tanatar A; Guliyeva V; Sönmez HE; Ayaz NA
    Vaccine; 2022 Mar; 40(12):1829-1836. PubMed ID: 35151508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19: Clinical features and outcomes in unvaccinated 2-dose and 3-dose vaccinated against SARS-CoV-2 patients with systemic autoimmune and autoinflammatory rheumatic diseases.
    Bakasis AD; Mavragani CP; Voulgari PV; Gerolymatou N; Argyropoulou OD; Vlachoyiannopoulos PG; Skopouli FN; Tzioufas AG; Moutsopoulos HM
    J Autoimmun; 2022 Jul; 131():102846. PubMed ID: 35717727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 breakthrough infections among vaccinated individuals with rheumatic disease: results from the COVID-19 Global Rheumatology Alliance provider registry.
    Liew J; Gianfrancesco M; Harrison C; Izadi Z; Rush S; Lawson-Tovey S; Jacobsohn L; Ja C; Hyrich KL; Gossec L; Strangfeld A; Carmona L; Schäfer M; Frãzao-Mateus E; Bulina I; Stafford F; Tufan A; Graver C; Yardımcı GK; Zepa J; Al Emadi S; Cook C; Abutiban F; Dey D; Katigbak G; Kaufman L; Kowalski E; Martínez-Martínez MU; Patel NJ; Reyes-Cordero G; Salido E; Smith E; Snow D; Sparks J; Wise L; Bhana S; Gore-Massy M; Grainger R; Hausmann J; Sirotich E; Sufka P; Wallace Z; Machado PM; Robinson PC; Yazdany J
    RMD Open; 2022 Apr; 8(1):. PubMed ID: 35387864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination of patients with inflammatory rheumatic diseases against SARS-CoV-2: considerations before widespread availability of the vaccines.
    Schulze-Koops H; Specker C; Skapenko A
    RMD Open; 2021 Feb; 7(1):. PubMed ID: 33627439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of hesitancy to COVID-19 vaccine in patients with rheumatic arthritis.
    Zeng HQ; Liu HJ; Wang SB; Yin ZH
    Eur Rev Med Pharmacol Sci; 2023 Aug; 27(16):7459-7469. PubMed ID: 37667922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-COV-2 vaccine acceptance in patients with rheumatic diseases: a cross-sectional study.
    Ko T; Dendle C; Woolley I; Morand E; Antony A
    Hum Vaccin Immunother; 2021 Nov; 17(11):4048-4056. PubMed ID: 34357827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parents' intent to vaccinate against influenza during the COVID-19 pandemic im two regions in Switzerland.
    Seiler M; Goldman RD; Staubli G; Hoeffe J; Gualco G; Manzano S
    Swiss Med Wkly; 2021 May; 151():w20508. PubMed ID: 35275392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 vaccination in patients with rheumatic diseases leads to a high seroconversion rate and reduced self-imposed isolation and shielding behaviour.
    Ammitzbøll C; Thomsen MK; Andersen JB; Bartels LE; Hermansen MF; Johannsen AD; Mistegaard CE; Mikkelsen S; Vils SR; Erikstrup C; Hauge EM; Troldborg A
    Mod Rheumatol; 2023 Jul; 33(4):777-785. PubMed ID: 35860843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronavirus disease 2019 vaccination uptake and hesitancy among Polish patients with inborn errors of immunity, autoinflammatory syndromes, and rheumatic diseases: A multicenter survey.
    Więsik-Szewczyk E; Ziętkiewicz M; Będzichowska A; Napiórkowska-Baran K; Matyja-Bednarczyk A; Felis-Giemza A; Jahnz-Różyk K
    Front Immunol; 2022; 13():1010899. PubMed ID: 36275663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry.
    Machado PM; Lawson-Tovey S; Strangfeld A; Mateus EF; Hyrich KL; Gossec L; Carmona L; Rodrigues A; Raffeiner B; Duarte C; Hachulla E; Veillard E; Strakova E; Burmester GR; Yardımcı GK; Gomez-Puerta JA; Zepa J; Kearsley-Fleet L; Trefond L; Cunha M; Mosca M; Cornalba M; Soubrier M; Roux N; Brocq O; Durez P; Conway R; Goulenok T; Bijlsma JW; McInnes IB; Mariette X
    Ann Rheum Dis; 2022 May; 81(5):695-709. PubMed ID: 34972811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.